Is treatment with oral topotecan plus best supportive care associated with better health status compared to best supportive care alone in small cell lung cancer?

被引：3
|
作者：
Chen, Lei
Antras, Lucia
Duh, Mei Sheng
Pickard, Simon
Cella, David
Neary, Maureen
O'Brien, Mary E.
机构：
[1] Anal Grp Inc, Boston, MA USA
[2] Univ Illinois, Chicago, IL USA
[3] Northwestern Univ, Evanston, IL USA
[4] GlaxoSmithKline Inc, Collegeville, PA USA
[5] Royal Marsden Hosp, Sutton, Surrey, England
来源：
JOURNAL OF THORACIC ONCOLOGY | 2007年 / 2卷 / 08期
关键词：
D O I：
10.1097/01.JTO.0000283255.61981.d8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S391 / S392
页数：2
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF ORAL TOPOTECAN PLUS BEST SUPPORTIVE CARE VERSUS BEST SUPPORTIVE CARE ALONE IN PATIENTS WITH RELAPSED SMALL-CELL LUNG CANCER (SCLC) IN THE UK
    Lykopoulos, K.
    Morris, S.
    Papo, N.
    O'Brien, M. E.
    VALUE IN HEALTH, 2008, 11 (06) : A482 - A482
  • [2] Cost-effectiveness of oral topotecan plus best supportive care versus best supportive care alone in patients with relapsed small-cell lung cancer (SCLC) in the UK
    O'Brien, Mary E.
    Morris, Stephen
    Papo, Natalie L.
    Lykopoulos, Konstantinos
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S818 - S818
  • [3] Cost-Utility Analysis of Maintenance Pemetrexed Plus Best Supportive Care Compared With Best Supportive Care Alone in Treating Patients With Non-Small Cell Lung Cancer in Jordan
    Al Rabayah, Abeer
    Al Froukh, Rawan
    Sawalha, Razan
    Al Shnekat, Maali
    Jahn, Beate
    Siebert, Uwe
    Jaddoua, Saad M.
    VALUE IN HEALTH REGIONAL ISSUES, 2024, 43
  • [4] Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer
    O'Brien, Mary E. R.
    Ciuleanu, Tudor-Eliade
    Tsekov, Hristo
    Shparyk, Yaroslav
    Cucevia, Branka
    Juhasz, Gabor
    Thatcher, Nicholas
    Ross, Graham A.
    Dane, Graham C.
    Crofts, Theresa
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (34) : 5441 - 5447
  • [5] Decision-making factors for best supportive care alone and prognostic factors after best supportive care in non-small cell lung cancer patients
    Kitazawa, Haruna
    Takeda, Yuichiro
    Naka, Go
    Sugiyama, Haruhito
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [6] Decision-making factors for best supportive care alone and prognostic factors after best supportive care in non-small cell lung cancer patients
    Haruna Kitazawa
    Yuichiro Takeda
    Go Naka
    Haruhito Sugiyama
    Scientific Reports, 9
  • [7] Chemotherapy versus best supportive care for extensive small cell lung cancer
    Pelayo Alvarez, Marta
    Gallego Rubio, Oscar
    Bonfill Cosp, Xavier
    Agra Varela, Yolanda
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (04):
  • [8] Chemotherapy versus best supportive care for extensive small cell lung cancer
    Pelayo Alvarez, Marta
    Westeel, Virginie
    Cortes-Jofre, Marcela
    Bonfill Cosp, Xavier
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (11):
  • [9] Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer
    Glimelius, B
    Ekstrom, K
    Hoffman, K
    Graf, W
    Sjoden, PO
    Haglund, U
    Svensson, C
    Enander, LK
    Linne, T
    Sellstrom, H
    Heuman, R
    ANNALS OF ONCOLOGY, 1997, 8 (02) : 163 - 168
  • [10] Chemotherapy Plus Best Supportive Care versus Best Supportive Care in Patients with Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials
    Zhong, Chenxi
    Liu, Hongcheng
    Jiang, Liyan
    Zhang, Wei
    Yao, Feng
    PLOS ONE, 2013, 8 (03):
12345